Finzati - Logo
NEXR logo

Nexera Technologies Ltd

NEXR • Biotechnology
$0.82
— 0.00 (0.00%)
EarningsLatest report: Dec 31, 2025
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$206,848.125
Growth
-23.1%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.47Healthy liquidity · 1.82Negative growth trendWeak profitability
Financial data as of: Dec 31, 2025, 12:00 AM UTCLast earnings update: Dec 31, 2025, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.83
Change0.00%
Shares Out250.72K
Market Cap$206.85K
Enterprise Value$937.85K
Beta1.49
P/E-0.02
P/S0.01
P/B0.02
P/FCF-0.02
EV/Sales0.03
EV/EBITDA-0.09

Investment DNA

How strong this company looks for long-term investors

40
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
57/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0.47Healthy liquidity · 1.82Negative growth trendWeak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 4/2/2026
Industry: Biotechnology
P/B i: 0.02
Debt / Equity i: 0.47
Operating Margin: -43.92%
Net Margin: -21.85%
ROE i: -
ROIC: -

Financial Health

Score11 / 20
Debt / Equity: 0.47
Current Ratio: 1.82
Quick Ratio: 0.70
Status: Moderate

Warnings

  • Weak quick ratio

Insider Transactions

Recent executive and insider activity

Etzyoni Tomer
Transaction: 03/18/2026
OTHER
Change
0
Price
Not reported
Filing
05/07/2026
Type
OTHER
Carmel Liron
Transaction: 03/18/2026
OTHER
Change
0
Price
Not reported
Filing
05/07/2026
Type
OTHER
Revach Moshe
Transaction: 03/18/2026
OTHER
Change
0
Price
Not reported
Filing
05/07/2026
Type
OTHER